4Filing Date: Sep 3, 2026
Humana
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0002151421-26-000004
Total Value$0
Trades1
Insiders1
Transaction Details
Nundy Shantanu
Chief Medical Officer·Direct
Grant · Acquire
Humana Common
Shares+2.55K
Price$0.00
Total Value$0
Shares Owned After2.55K
Transaction DateSep 1, 2026
Footnotes ▸
Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.
Post-Transaction Holdings
Nundy Shantanu · Chief Medical Officer
| Security | Shares | Change |
|---|---|---|
| Humana Common | 2.55K | +2.55K |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-09-01
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: HUMANA INC (HUM)
CIK: 0000049071
--- Reporting Owner ---
Name: Nundy Shantanu
CIK: 0002151421
Role: Officer (Chief Medical Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Humana Common
Date: 2026-09-01 | Code: A (Grant or award)
Shares: +2,549 | Price: $0.00
Shares Owned After: 2,549 | Ownership: D (Direct)
Footnotes:
[F1] Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.
--- Footnotes (Complete Index) ---
F1: Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.
--- Signature ---
/s/ Shantanu Nundy (2026-09-03)